|Daily Range||$9.65 - $10.10|
|52-Week Range||$3.80 - $11.48|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||10,859,247|
|Current FY EPS||-$0.37|
How do you think MNKD
will perform against the market?
Top MNKD Bull/Bear Pitches
Submitted June 18, 2014
Inhalable insulin might become a game changer. The technosphere technology might also be useful for a number of different drugs, and the CEO Al Mann has experience bringing medical devices to market … More
usubanas (< 20)
Submitted March 28, 2014
predict FDA panel will vote negatively next week.
News & Commentary
MannKind Corp (MNKD) Description
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/